Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that frequently affects aging men [5]. As the prostate grows, it can cause lower urinary tract symptoms (LUTS) that impact daily life and overall well-being [7]. Primary care providers play an essential role in recognizing these signs early, performing physical examinations, and starting appropriate medical therapies [1]. Understanding the full spectrum of symptoms and treatment pathways helps patients make informed decisions about their urological health.
Recognizing Lower Urinary Tract Symptoms
The symptoms associated with an enlarged prostate are generally categorized into voiding, storage, and post-micturition issues [8]. Because the growing tissue obstructs the flow of urine from the bladder, men commonly experience several distinct physical signs [5]:
- A weak or interrupted urinary stream [5]
- Straining during urination or difficulty starting the flow [5]
- A frequent or urgent need to urinate, particularly at night [5]
- A sensation of incomplete bladder emptying [5]
These urinary challenges can significantly reduce a patient's quality of life [7]. When evaluating these issues, clinicians also consider overlapping conditions, as bladder dynamics and aging can influence storage symptoms alongside prostate enlargement [8].
Initial Medical Management Approaches
Fortunately, many men find relief through non-surgical interventions, transforming BPH from an acute surgical problem into a manageable chronic condition [7]. Physicians typically prescribe specific drug classes to relax surrounding smooth muscle or shrink the prostate tissue [1]:
- Alpha-blockers: Medications that relax the muscles around the prostate and bladder neck to improve urine flow [1, 7].
- 5-Alpha Reductase Inhibitors (5ARIs): Drugs like finasteride that block testosterone conversion, gradually reducing prostate size and lowering the long-term risk of acute urinary retention [5, 7].
- Additional Options: Phosphodiesterase-5 inhibitors and antimuscarinic agents are sometimes utilized to help manage specific storage or co-existing symptoms [1, 7, 8].
When Surgery Becomes Necessary
While medications successfully control symptoms for many patients, some individuals reach a point where additional evaluation by a urologist and surgical intervention are required [1]. Surgery is typically considered when medical therapies fail to provide adequate relief, or when complications arise, such as recurrent urinary retention, bladder stones, or kidney issues. Primary care clinicians coordinate closely with specialists to determine the optimal timing for these procedures [1].
Traditional and Minimally Invasive Surgical Options
The landscape of surgical treatment has evolved significantly over the years, offering choices that range from traditional resections to modern office-based procedures [2, 3]. Transurethral resection of the prostate (TURP) has long served as the historical gold standard for relieving bladder outlet obstruction, benefiting from decades of technological advancements in lighting, optics, and surgical technique [3]. For very large glands, open, laparoscopic, or robotic simple prostatectomy may be performed [3].
In addition to traditional methods, newer minimally invasive office-based therapies have emerged [2]. Procedures such as the Prostatic Urethral Lift (UroLift) use permanent implants to hold open the obstructed urethral lobes, while convective water vapor ablation (Rezum) utilizes thermal energy to reduce excess prostate tissue [2, 6]. Clinical studies demonstrate that these office-based treatments can be performed under local anesthesia, offering shorter catheterization times, rapid recovery, and preservation of sexual function while effectively relieving symptoms [2, 6].
Sources
1. BPH update: medical versus interventional management. The Canadian journal of urology, 2016.
2. Office-based therapies for benign prostatic hyperplasia: a review and update. The Canadian journal of urology, 2019.
3. Electroresection and open surgery. The Urologic clinics of North America, 2009.
4. Techniques and long-term results of surgical procedures for BPH. European urology, 2006.
5. Finasteride for benign prostatic hyperplasia. The Cochrane database of systematic reviews, 2010.
6. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. The Canadian journal of urology, 2017.
7. Lower urinary tract symptoms in men. BMJ (Clinical research ed.), 2014.
8. Male lower urinary tract symptoms: how do symptoms guide our choice of treatment? Current opinion in urology, 2009.